Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Nanotechnology and Life Sciences: Science and Business Perspectives

Abstract:
Dr Mostafa Analoui, PHD, Senior Director at Pfizer Global Research and Development is confirmed to speak on critical needs in clinical diagnostics and key challenges in drug discovery and development at Biopharmaceutical Nanotechnology http://www.iqpc.com/uk/nanotech/nnow in London, UK on 31st March - 1st April 2008.

Nanotechnology and Life Sciences: Science and Business Perspectives

Connecticut, USA and London, UK | Posted on January 17th, 2008

Research and Development in Life Sciences are greatly impacted by recent advances in conventional and emerging technologies, especially in understanding of disease, drug discovery, and novel diagnostics. These technological contributions have led to innovation and introduction of a number of therapeutic solutions with notable improvement in public health. Nanobiotechnology, a basket of wide ranging technologies, is being positioned as one of critical class of technologies, with broad reaching impacts in Life Science R&D, including drug discovery, formulation, delivery, clinical assessment and monitoring.

Nanobiotechnology's impact within drug discovery and development is manifesting itself in two ways, with different time horizons. The immediate and short term impact is being materialized through innovative formulation and delivery of compounds in different stages of development, including the ones already in the market. In the longer term horizon, there is a promise of new class of drugs designed around nanobiotechnology approach from ground up. There are early indicators of such potential success stories worth allocating resources and attention.

Dr Mostafa Analoui's presentation at the Biopharmaceutical Nanotechnology conference in London, UK will discuss some of the areas that nanobiotechnology could play through enhancement in current paradigm, as well as new directions in drug development, using examples of current utility of nanotechnology, as well as ongoing research areas. Dr Analoui will also provide delegates with a snapshot of global business and investment environment around nanobiotechnology, including current and projected level of private and government investments, trends in IP ownership, as well as fundamental questions around assessment of investment strategies and risks.

As well as being a Senior Director at Pfizer Global Research and Development in Connecticut Dr Analoui is also adjunct Professor of Radiology and Oral Pathology, Medicine at Indiana University Schools of Medicine and Dentistry. Dr Analoui is actively involved in management and scientific/business development of novel biotechnologies and methodologies, global strategies and education. Dr Analoui was previously the Director of Oral and Maxillofacial Imaging Research at Indiana University, and Associate professor of Biomedical Engineering and Electrical & Comp Engineering at Purdue University. He was also President and CEO of Therametric Technology Inc.

In addition to industry leadership in biomedical filed, he lectures nationally and internationally. He has also served on various scientific and business advisory committees and boards. Dr. Analoui has authored over 130 publications, including journal articles, book chapters, and technical reports.

####

About Biopharmaceutical Nanotechnology 2008
The use of Nanotechnology in the discovery and development of biopharmaceuticals is a major breakthrough, with the potential to revolutionise and enhance your ability to develop new and innovative products.

Biopharmaceutical Nanotechnology is the first industry-led event in Europe focussing on drug discovery, drug delivery and particular therapeutic areas. Join global experts for a practical, commercially applicable perspective on how to:

Stay competitive by applying the experience of key industry players who have used nanotechnology in the administration of drugs

Discover how nanotechnology combines drugs and devices to increase your product efficiency

Learn the best ways to implement drug discovery techniques into your business processes

Discuss how to employ latest therapeutic developments into your product pipeline

For further information, visit http://www.iqpc.com/uk/nanotech/nnow

For more information, please click here

Copyright © Biopharmaceutical Nanotechnology 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Virginia Tech physicists propose path to faster, more flexible robots: Virginia Tech physicists revealed a microscopic phenomenon that could greatly improve the performance of soft devices, such as agile flexible robots or microscopic capsules for drug delivery May 17th, 2024

Gene therapy relieves back pain, repairs damaged disc in mice: Study suggests nanocarriers loaded with DNA could replace opioids May 17th, 2024

Shedding light on perovskite hydrides using a new deposition technique: Researchers develop a methodology to grow single-crystal perovskite hydrides, enabling accurate hydride conductivity measurements May 17th, 2024

Oscillating paramagnetic Meissner effect and Berezinskii-Kosterlitz-Thouless transition in cuprate superconductor May 17th, 2024

Announcements

Virginia Tech physicists propose path to faster, more flexible robots: Virginia Tech physicists revealed a microscopic phenomenon that could greatly improve the performance of soft devices, such as agile flexible robots or microscopic capsules for drug delivery May 17th, 2024

Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024

Finding quantum order in chaos May 17th, 2024

Oscillating paramagnetic Meissner effect and Berezinskii-Kosterlitz-Thouless transition in cuprate superconductor May 17th, 2024

Events/Classes

Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023

CEA & Partners Present ‘Powerful Step Towards Industrialization’ Of Linear Si Quantum Dot Arrays Using FDSOI Material at VLSI Symposium: Invited paper reports 3-step characterization chain and resulting methodologies and metrics that accelerate learning, provide data on device pe June 17th, 2022

June Conference in Grenoble, France, to Explore Pathways to 6G Applications, Including ‘Internet of Senses’, Sustainability, Extended Reality & Digital Twin of Physical World: Organized by CEA-Leti, the Joint EuCNC and 6G Summit Sees Telecom Sector as an ‘Enabler for a Sustainabl June 1st, 2022

How a physicist aims to reduce the noise in quantum computing: NAU assistant professor Ryan Behunin received an NSF CAREER grant to study how to reduce the noise produced in the process of quantum computing, which will make it better and more practical April 1st, 2022

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project